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B lineage expression of the 67-kD pan–T-cell 
antigen CD5 was first detected on the surface 
of certain human and murine malignancies   
30 yr ago, and was subsequently identified on a 
subset of normal B cells in both species (Kantor 
and Herzenberg, 1993; Morris and Rothstein, 
1994;  Hardy  and  Hayakawa,  2001).  In  mice, 
CD5 expression identifies a distinct B cell lin-
eage, termed B1, which manifests unique onto-
logical, anatomical, and functional characteristics. 
In contrast to conventional B2 cells, murine B1 
cells  derive  from  CD19+B220  progenitors, 
appear early in development, and preferentially 
locate to coelomic cavities (Herzenberg, 2000; 
Berland  and  Wortis,  2002;  Rothstein,  2002; 
Dorshkind and Montecino-Rodriguez, 2007). 
Most importantly, B1 cells differ functionally 
from B2 cells by spontaneously secreting “natu-
ral” Ig that is generated in the absence of spe-
cific  immunization  and  which  accounts  for 
most of the resting IgM, and a large portion of 
the resting IgA, found in normal serum (Sidman 
et al., 1986; Forster and Rajewsky, 1987; Ishida 
et al., 1992; Kroese et al., 1993). This B1 cell–
derived natural Ig differs from B2 cell–derived 
antibody because it is more germline-like as a 
result of minimal N-region addition and so-
matic hypermutation—and is broadly reactive, 
autoreactive, and repertoire-selected (Forster   
et  al.,  1988;  Hayakawa  and  Hardy,  1988;   
Hardy et al., 1989; Pennell et al., 1989; Gu et al., 
1990).  Natural  Ig  is  vitally  important  in  the 
early defense against bacterial and viral infec-
tions (Briles et al., 1981; Boes et al., 1998; 
Ochsenbein et al., 1999; Baumgarth et al., 2000; 
Haas et al., 2005), and may play a role in a 
wide variety of diseases through recognition of   
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B1 cells differ in many ways from conventional B cells, most prominently in the production 
of natural immunoglobulin, which is vitally important for protection against pathogens.  
B1 cells have also been implicated in the pathogenesis of autoimmune dyscrasias and 
malignant diseases. It has been impossible to accurately study B1 cells during health and illness 
because the nature of human B1 cells has not been successfully defined. This has produced 
controversy regarding the existence of human B1 cells. Here, we determined the phenotype 
of human B1 cells by testing sort-purified B cell fractions for three fundamental B1 cell 
functions based on mouse studies: spontaneous IgM secretion, efficient T cell stimulation, and 
tonic intracellular signaling. We found that a small population of CD20+CD27+CD43+ cells 
present in both umbilical cord and adult peripheral blood fulfilled these criteria and ex-
pressed a skewed B cell receptor repertoire. These B cells express little or no surface CD69 
and CD70, both of which are markedly up-regulated after activation of CD20+CD27CD43 
(naive) and CD20+CD27+CD43 (memory) B cells. This work identifies human B1 cells as 
CD20+CD27+CD43+CD70. We determined that the proportion of B1 cells declines with 
age, which may contribute to disease susceptibility. Identification of human B1 cells provides 
a foundation for future studies on the nature and role of these cells in human disease.
© 2011 Griffin et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it  is  available  under  a  Creative  Commons  License  (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e68 Identification of human B1 cells | Griffin et al.
we first examined umbilical cord blood specimens for spon-
taneous IgM secretion by ELISPOT assay, which we used for 
initial screening, and then looked for efficient T cell stimula-
tion and tonic intracellular signaling. We isolated B cells that 
were CD20+ to avoid CD19+CD20 plasmablasts that might 
secrete IgM.
Umbilical cord blood contains CD20+CD27+CD43+ B cells
Initially, we sort-purified CD20+ B cells from umbilical cord 
blood  samples,  and  then  tested  for  IgM  secretion  in  3-h 
ELISPOT assays. We found that unstimulated cord blood B 
cells spontaneously generated IgM-containing ELISPOTs 
(unpublished data). To phenotypically characterize the Ig- 
secreting population, we examined various CD20+ cord blood 
populations defined by known B cell surface antigens. Among 
these populations, we unexpectedly identified a small subset 
of CD27+ cells, ranging from 3 to 11% of CD20+ B cells. 
Similar numbers of CD27+ cord blood B cells were detected 
by a variety of different anti-CD27 immunofluorescent re-
agents (unpublished data), and expression of CD27 mRNA 
coincident with expression of CD27 surface antigen was 
verified  by  real-time  PCR  conducted  on  sort-purified 
CD20+CD27+ and CD20+CD27 cord blood cells (unpub-
lished data). These CD20+CD27+ cord blood B cells uniquely 
express CD43, a well-described marker for murine B1 cells 
(Wells et al., 1994), whereas CD20+CD27 cord blood B cells 
are CD43 (Fig. 1 A). Thus, CD20+ cord blood B cells segre-
gate  into  two  populations,  CD27+CD43+  (amounting  to   
6.1 ± 1.1%; mean ± SEM; n = 13) and CD27CD43 (amount-
ing to 93.9 ± 1.1%).
Umbilical cord blood CD20+CD27+CD43+ B cell Igs express 
few mutations
In the human system, CD27 expression is generally con-
sidered to mark memory B cells (Agematsu et al., 2000), 
which suggests incongruity in the identification of CD27+ 
B cells in cord blood that is obtained at birth before exog-
enous antigen exposure. To clarify the nature of umbilical 
cord  blood  CD20+CD27+CD43+  B  cells,  we  examined   
the mutational status of Ig amplified from single cells, as   
described  in  Materials  and  methods.  In  contrast  to  the 
large number of somatic mutations present in adult CD27+ 
B cell–derived antibodies (Klein et al., 1998), we found 
that all cord blood B cells express antibodies with very   
low levels of somatic mutation, both CD20+CD27+CD43+ 
and  CD20+CD27CD43  B  cells  (Table  I,  Fig.  S1  and   
Tables S1 and S2). All cord blood CD27+CD43+ B cell Ig 
sequences contained N region additions at the V–D and 
D–J  junctions,  much  like  CD27CD43  B  cell  Ig  se-
quences (Table I) reflecting the presence of terminal de-
oxynucleotidyl  transferase  throughout  ontogeny  in  the 
human  system  (Asma  et  al.,  1986). Among  cord  blood   
B cells, CD27 expression does not correlate with increased 
Ig mutational status and does not correspond to memory   
B cell status, and thus is presumably indicative of another 
B cell population.
self-antigens and binding of cellular debris (Binder and   
Silverman, 2005). In addition, B1 cells differ functionally from 
B2 cells in efficiently presenting antigen to T cells (Zhong   
et al., 2007) and in displaying evidence of tonic signaling 
(Karras et al., 1997; Wong et al., 2002; Holodick et al., 2009b) 
in the “resting” state in the absence of specific stimulation. 
Somewhat akin to anergic B cells, B1 cells are relatively non-
responsive to B cell receptor (BCR) engagement (Morris and 
Rothstein, 1993; Wong et al., 2002). Whereas B1 cells have 
been considered to be self-renewing, and thus self-perpetuat-
ing, in adult animals (Hayakawa et al., 1986; Kantor et al., 
1995), recent evidence suggests that new bone marrow emi-
grants are continually added to the B1 cell pool (Duber et al., 
2009; Holodick et al., 2009a).
A subpopulation of CD5-expressing B cells is found in 
various human tissues; these CD5+ B cells are capable of   
autoantibody production, and the number of such CD5+  
B cells is expanded in some autoimmune diseases (Plater- 
Zyberk et al., 1985; Taniguchi et al., 1987; Burastero et al., 
1988; Dauphinee et al., 1988). The significance of these find-
ings vis a vis B1 cells is uncertain, however, because it is not 
clear that CD5 is a durable marker of the B1 cell population 
across species. Not only is CD5 expressed on B2 cell popula-
tions in the human system (including transitional, prenaive, 
and activated B cells), but in other mammals CD5 is nondis-
criminatory (Freedman et al., 1989; Raman and Knight, 1992; 
Sims et al., 2005; Wilson and Wilkie, 2007; Lee et al., 2009). 
Further, both CD5 and CD5+ B cells can produce IgM   
autoantibodies (Casali and Notkins, 1989; Kasaian et al., 
1992; Mackenzie et al., 1991). As a result, there has been much 
controversy regarding whether B1 cells exist at all in Homo 
sapiens, and if so, how human B1 cells might be characterized. 
Resolution of this problem is of great importance, because a 
full understanding of the relationship between B1 cells and 
diseases ranging from autoimmune dyscrasias to lymphoid 
malignancies, and the development of therapeutics to enhance 
natural Ig, depends on elucidating identifying features that 
will allow human B1 cells to be readily enumerated and func-
tionally evaluated in clinical situations. To address this issue, 
we screened various phenotypically defined populations from 
umbilical cord and adult peripheral blood for key characteris-
tics of the well-studied murine B1 cell population, specifi-
cally, spontaneous IgM secretion, efficient T cell stimulation, 
and tonic intracellular signaling. Using these functional crite-
ria, we identified the phenotypic profile for human B1 cells as 
CD20+CD27+CD43+CD70.  We  determined  that  some 
characteristics attributed to human memory B cells identified 
on the basis of CD27 expression are actually produced by 
(CD27+) B1 cells.
RESULTS
In the murine system, B1 cell progenitors are more abundant 
in fetal hematopoietic tissues than in adult hematopoietic tissues, 
and B1 cells emerge before the bulk of B2 cell production occurs   
(Montecino-Rodriguez et al., 2006). Following this paradigm, JEM VOL. 208, January 17, 2011 
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we  examined  tonic  intracellular  signaling  by  phosphoflow 
analysis, in which tyrosine phosphorylation of phosphol-
ipase C gamma 2 (PLC-2) and spleen tyrosine kinase (Syk) 
was  readily  visualized  by  intracellular  immunofluorescent 
staining after inhibition of phosphatase activity. Untreated 
B cells showed little evidence of phosphorylated PLC-2 or 
phosphorylated Syk. Within minutes of phosphatase inhibi-
tion, we found that CD20+CD27+CD43+ B cells expressed 
substantial levels of phosphorylated PLC-2 and phosphor-
ylated Syk, which increased further with time, whereas the 
levels of phosphorylated PLC-2 and phosphorylated Syk in 
CD20+CD27CD43 B cells did not change (Fig. 2). Thus, 
the small population of CD20+CD27+CD43+ cord blood 
B cells displays tonic intracellular signaling that is apparent 
when phosphatase activity is inhibited, whereas the majority 
of cord blood B cells that are negative for CD27 expression 
do not.
In sum, on the basis of spontaneous IgM secretion, effi-
cient T cell stimulation, tonic intracellular signaling, and 
low level Ig somatic mutation, CD20+CD27+CD43+ cord 
blood B cells appear to fulfill the functional criteria for B1 
cell status.
Adult peripheral blood CD20+CD27+CD43+ B cells 
spontaneously secrete IgM
Following the strategy outlined for umbilical cord blood B cells, 
we sort-purified CD20+ B cells from adult peripheral blood 
samples, and then tested for IgM secretion in 3-h ELISPOT 
assays. We found that unstimulated adult B cells spontaneously 
Umbilical cord blood CD20+CD27+CD43+ B cells 
spontaneously secrete IgM
We sort-purified cord blood CD20+ B cells and found that 
CD27 expression (and synonymous CD43+ expression) neatly 
and completely separated cord blood B cells that spontane-
ously  secrete  IgM  from  those  that  do  not,  as  shown  by 
ELISPOT (Fig. 1 B,C) and ELISA (Fig. 1 D) analyses. Thus, a 
small population of CD20+CD27+CD43+ B cells, amounting 
on average to <10% of total B cells, is responsible for sponta-
neous IgM secretion in this tissue.
Umbilical cord blood CD20+CD27+CD43+ B cells efficiently 
stimulate T cells
To determine the extent to which IgM-secreting umbilical 
cord  blood  CD20+CD27+CD43+  B  cells  express  other 
characteristics derived from murine B1 cell studies, we ex-
amined the efficiency of CD4+ T cell allogeneic stimulation 
produced by irradiated B cell populations, assessed by thy-
midine incorporation. We found that CD20+CD27+CD43+ 
B cells strongly stimulated T cell proliferation over a 5-d 
period,  whereas  CD20+CD27CD43  B  cells  had  little   
effect (Fig. 1 E). Thus, not only do CD20+CD27+CD43+  
B cells efficiently stimulate T cells, but this functional char-
acteristic  is  completely  restricted  to  the  CD27+CD43+  
B cell population.
Umbilical cord blood CD20+CD27+CD43+ B cells exhibit 
tonic intracellular signaling
To  further  evaluate  the  extent  to  which  IgM-secreting,   
T  cell–stimulating  umbilical  cord  blood  CD20+CD27+ 
CD43+ B cells express other murine B1 cell characteristics, 
Figure 1.  Umbilical cord blood CD20+CD27+CD43+  
B cells spontaneously secrete IgM and efficiently stimu-
late T cells. (A) Umbilical cord blood mononuclear cells were 
stained with immunofluorescent antibodies and evaluated by 
flow cytometry. The contour plot displays expression of CD27 
and CD43 by gated CD20+ cells. Results shown represent 1  
of 13 separate cord blood samples. (B) Sort-purified 
CD20+CD27CD43 (2743) and CD20+CD27+CD43+ 
(27+43+) cord blood B cells were plated at 1 × 104 cells per 
well, incubated for 3 h at 37°C, and analyzed for IgM secretion 
by ELISPOT. Images shown are representative of three separate 
experiments on three different cord blood samples each done 
in triplicate. (C) Enumeration of ELISPOT results displayed as 
mean values for triplicate wells, with error bars indicating  
the SEM. Each bar graph indicates an individual experiment  
on a separate cord blood sample. (D) Sort-purified 
CD20+CD27CD43 and CD20+CD27+CD43+ cord blood B cells 
were cultured for 5 d, after which supernatants were evalu-
ated for secreted IgM by ELISA. Each bar graph indicates an 
individual experiment on a separate cord blood sample.  
(E) Sort purified and irradiated CD20+CD27CD43 (2743) 
and CD20+CD27+CD43+ (27+43+) cord blood B cells were eval-
uated for the ability to drive allogeneic T cell proliferation as 
measured by tritiated thymidine incorporation for 8 h at the 
end of 5 d co-cultures. Data shown are representative of three 
separate experiments on three different cord blood samples 
each done in triplicate. Mean cpm values are displayed with 
error bars indicating SEM.70 Identification of human B1 cells | Griffin et al.
as  compared  with  CD20+CD27+CD43+ B cells (unpub-
lished data).
Adult peripheral blood CD20+CD27+CD43+ B cells efficiently 
stimulate T cells
To  determine  the  extent  to  which  IgM-secreting 
CD20+CD27+CD43+ adult peripheral blood B cells express 
other B1 characteristics (and recapitulate the features of cord 
blood CD20+CD27+CD43+ B cells), we examined the effi-
ciency of allogeneic CD4+ T cell stimulation produced by irra-
diated B cell populations. We found that CD20+CD27+CD43+ 
B  cells  strongly  stimulated T  cell  proliferation,  whereas 
CD20+CD27+CD43 B cells, and CD20+CD27CD43  
B  cells,  had  little  effect  (Fig.  3  E).  In  particular, 
CD20+CD27+CD43+ B cells exceeded CD20+CD27+CD43 
B cells by >50-fold in the ability to stimulate T cell prolifera-
tion. Thus, in comparison with the bulk of adult peripheral   
B cells that do not express CD43, only the small population of 
CD20+CD27+CD43+ B cells efficiently stimulates T cells.
generated IgM-containing ELISPOTs, and that IgM secretion 
segregated with CD27 expression (unpublished data). We then 
extrapolated  from  our  umbilical  cord  blood  studies,  in 
which CD43 expression coincided with CD27 expression on a 
nonmemory B cell population, to separate adult peripheral 
blood CD20+CD27+ B cells according to CD43 expression. 
In so doing, CD27 and CD43 defined 3 distinct populations 
of  CD20+  B  cells:  CD27+CD43+  (12.7  ±  1.6%  of  total 
CD20+ B cells; mean ± SEM; n = 25), CD27+CD43 (19.6 ± 
2.2%), and CD27CD43 (67.7 ± 2.4%; Fig. 3 A), the first 
of which parallels the phenotype of IgM-secreting cord blood 
B cells. Indeed, when tested by ELISPOT (Fig. 3, B and C)   
and  ELISA  (Fig.  3  D),  we  found  that  only  the  small 
CD20+CD27+CD43+ population from adult blood spon-
taneously secreted IgM, recapitulating the results obtained 
with the comparable cord blood B cell population. Fur-
ther,  CD20+CD27+CD43  and  CD20+CD27CD43  
B cells were negative for spontaneously secreted IgM, even 
when 10-fold more of these cells were plated on ELISPOT 
Table I.  Umbilical cord blood CD20+CD27+CD43+ B cell immunoglobulins express few mutations
B cell populations Total mutations 
(no. of bases)
VH mutations 
(no. of bases)
N1 additions 
(no. of bases)
N2 additions 
(no. of bases)
CDR3 length 
(no. of bases)
B1: CD20+CD27+CD43+ 2.0 ± 0.3 0.14 ± 0.05 6.8 ± 1.2 3.8 ± 0.7 14.5 ± 0.7
B2: CD20+CD27CD43 1.9 ± 0.4 0.08 ± 0.06 6.4 ± 0.8 4.6 ± 0.8 14.8 ± 0.7
Number of cells analyzed: B1, n = 43; B2, n = 25. Mean number ± SEM.
Figure 2.  Umbilical cord blood CD20+CD27+CD43+ B cells exhibit tonic intracellular signaling. (A) Cord blood mononuclear cells were unexposed 
(0) or were exposed to pervanadate for 4, 8, and 12 min and then fixed, permeabilized and stained for surface antigens and intracellular phosphorylated 
PLC-2 with specific immunofluorescent antibodies. Because isotype control antibody staining by “fluorescence minus one” did not vary between the two 
cell populations being studied, only a single control tracing is shown. Results for one of three comparable experiments are shown. (B) Mean values of 
mean fluorescence intensity (MFI) are shown (with error bars indicating the SEM) for intracellular phosphorylated PLC-2 staining at various time points 
from three separate umbilical cord blood samples. (C) Cord blood mononuclear cells were unexposed (0) or were exposed to pervanadate for 4, 8, or  
12 min, and then fixed, permeabilized, and stained for surface antigens and intracellular phosphorylated Syk with specific immunofluorescent antibodies. 
Results for one of three comparable experiments are shown. (D) Mean values of MFI are shown (with error bars indicating the SEM) for intracellular phos-
phorylated Syk staining at various time points from three separate umbilical cord blood samples.JEM VOL. 208, January 17, 2011 
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that human CD5 B cells produce autoantibodies (Mackenzie 
et al., 1991; Kasaian et al., 1992). Because the repertoire of   
human B1 cells might well differ from murine B1 cells in terms 
of pathogenic microbes and self-antigens in view of the tens   
of millions of years that have passed since murine and human 
evolution diverged, we did not initially use specificity criteria 
based on the mouse system to identify human B1 cells. How-
ever, having determined the phenotype of human B1 cells, it was 
of interest to examine whether, as in murine B1 cells, the reper-
toire of CD20+CD27+CD43+ B1 cells is weighted in favor of 
antimicrobial and autoantibody specificities. To address this is-
sue, we exposed human adult peripheral blood mononuclear 
cells to phosphorylcholine (PC; Lalor and Morahan, 1990) and 
to  aspartate-tryptophan-glutamate-tyrosine-serine  (DWEYS) 
tetramer DNA mimetope (Shirai et al., 1991; Jacobi et  al., 
2009) and determined the level of binding to CD20+CD27+ 
CD43+ (B1), CD20+CD27+CD43 (memory), and CD20+ 
CD27CD43 (naive) B cells, as described in Materials and 
methods. We found that only B1 cells, and not memory or naive 
B cells, contained a substantial number of PC-binding and mi-
metope-binding  antigen  receptors  (Fig.  5). Thus,  human   
B1 cells are similar to murine B1 cells in displaying a skewed 
antigen receptor repertoire as indicated by preferential expres-
sion of anti-PC and anti-DNA specificities.
CD20+CD5+ B cells are not the same  
as CD20+CD27+CD43+ B1 cells
Inasmuch as human CD5+ B cells have been reported to ex-
press autoreactive specificities, our results raise the question of 
Adult peripheral blood CD20+CD27+CD43+ B cells exhibit 
tonic intracellular signaling
To  further  evaluate  IgM-secreting, T  cell–stimulating  adult   
peripheral blood B cells, we examined tonic intracellular signal-
ing by phosphoflow analysis of phosphorylated PLC-2 and 
Syk, as described earlier. Untreated B cells showed little evi-
dence of phosphorylated PLC-2 or phosphorylated Syk. As 
with cord blood B cells, within minutes of phosphatase inhibi-
tion we found that CD20+CD27+CD43+ B cells expressed sub-
stantial levels of phosphorylated PLC-2 and phosphorylated 
Syk, whereas the levels of phosphorylated PLC-2 and phos-
phorylated Syk in CD20+CD27+CD43 and CD20+CD27 
CD43 B cells changed little (Fig. 4). Thus, the small popula-
tion of CD20+CD27+CD43+ adult blood B cells, and only that 
population, displays tonic intracellular signaling.
In sum, because CD20+CD27+CD43+ adult blood B cells 
reproduce the characteristics of CD20+CD27+CD43+ cord 
blood B cells in manifesting three key B1 cell functional char-
acteristics,  CD27  and  CD43  identify  a  B  cell  population 
throughout ontogeny that represents the human equivalent   
of murine B1 cells. Additional surface antigens displayed by 
CD20+CD27+CD43+ B cells (as single peak expression with 
>90%  positive)  are  as  follows:  IgD,  CD19,  CD21,  CD44, 
CD45RB, and HLA-DR (Fig. S2).
CD20+CD27+CD43+ B1 cells display two typical  
B1 cell specificities
The production of particular antimicrobial and autoantibody 
specificities is a well-described characteristic of murine B1 cells 
(Hayakawa et al., 1984) and it has been reported that auto-
reactive Ig is preferentially produced by human CD5+ B cells 
(Casali and Notkins, 1989), although it has also been reported 
Figure 3.  Adult peripheral blood CD20+CD27+CD43+  
B cells spontaneously secrete IgM and efficiently stimulate 
T cells. (A) Adult peripheral blood mononuclear cells were 
stained with immunofluorescent antibodies and evaluated by 
flow cytometry. The contour plot displays expression of CD27 and 
CD43 by gated CD20+ cells. Results shown represent 1 of 25 
separate peripheral blood samples. (B) Sort-purified 
CD20+CD27CD43 (2743), CD20+CD27+CD43 (27+43), and 
CD20+CD27+CD43+ (27+43+) adult peripheral blood B cells were 
plated at 1 × 104 cells per well, incubated for 3 h at 37°C, and 
analyzed for IgM secretion by ELISPOT. Images shown are repre-
sentative of three separate experiments on three different adult 
blood samples each done in triplicate. (C) Enumeration of ELISPOT 
results displayed as mean values for triplicate wells, with error 
bars indicating SEM. Each bar graph indicates an individual ex-
periment on a separate adult blood sample. (D) Sort-purified 
CD20+CD27+CD43+, CD20+CD27+CD43, and CD20+CD27CD43 
adult blood B cells were cultured for 5 d, after which superna-
tants were evaluated for secreted IgM by ELISA. Each bar graph 
indicates an individual experiment on a separate adult blood 
sample. (E) Sort-purified and irradiated CD20+CD27CD43 
(2743), CD20+CD27+CD43 (27+43), and CD20+CD27+CD43+ 
(27+43+) adult peripheral blood B cells were evaluated for the 
ability drive allogeneic T cell proliferation as measured by triti-
ated thymidine incorporation for 8 h at the end of 5-d cultures. 
Data shown are representative of three separate experiments on 
three different blood samples each done in triplicate. Mean cpm 
values are displayed with error bars indicating SEM.72 Identification of human B1 cells | Griffin et al.
nearly 100% in cord blood to <20%, on average, in the eighth 
decade and older (Fig. 7). We used various regression models 
to examine this trend; the cubic model had a higher R-squared 
than the quadratic model and the line so generated is shown. 
The same data were separately evaluated by comparing samples 
from individuals under age 20, between 20 and 50, between 
50 and 75, and between 75 and 90 years of age. This comparison 
shows a progressive loss of CD43+ B cells among CD20+CD27+ 
B cells with increasing age, amounting to more than fourfold 
between the youngest and oldest age groups.
Expression of CD69 and CD70 differentiates B1 cells  
from activated memory and naive B cells
Although in the murine system CD43 marks B1 cells and 
only appears on mature B2 cells during terminal differentia-
tion (Gulley et al., 1988), we considered the possibility that 
CD43 might be inducible in the human system, much like 
CD5 (Freedman et al., 1989; Cong et al., 1991). In such an 
instance, CD20+CD27+CD43+ B cell populations could con-
tain an unknown number of activated B cells in addition to 
B1 cells. To address this possibility, we cultured CD20+CD43 
adult peripheral blood B cells (both CD27+ and CD27), 
with medium alone, or with LPS, CpG, anti-IgM, Staphylococ-
cus aureus Cowan strain 1 (SAC) plus IL-2, PMA plus iono-
mycin, and anti-CD40 plus anti-IgM, for 4 d and reassessed 
expression of CD43. Although many stimuli, including BCR 
the relationship between CD5+ B cells and CD27+CD43+ B1 
cells. To address this issue, we immunofluorescently stained 
and analyzed adult peripheral blood CD20+ B cells for CD5, 
CD27, and CD43. We found that CD20+CD27+CD43+  
B cells were largely CD5+, with 75 ± 2.5% (mean ± SEM; 
n = 46) expressing CD5 (Fig. 6 and Fig. S2 B). However, 
CD20+CD27+CD43+ B1 cells comprised only a minority 
(34 ± 3.0%) of CD20+CD5+ B cells, so that approximately 2/3 
of CD20+CD5+ B cells were outside the CD20+CD27+CD43+ 
B1 cell pool. Thus, B cell positivity for CD5 captures ap-
proximately  3/4,  but  misses  approximately  1/4,  of  human 
CD20+CD27+CD43+ B1 cells, and includes many B cells that 
are not B1 cells, consistent with reports that CD5 marks pre-
naive, transitional, and activated B cell populations.
CD20+CD27+CD43+ B1 cells decline with age  
in normal individuals
To evaluate the variation in B cell populations among normal 
individuals and with advancing age, we screened 6 umbilical 
cord and 43 adult peripheral blood samples obtained from 
normal volunteers. As expected, the fraction of B cells ex-
pressing CD27 that lack CD43 (CD20+CD27+CD43) in-
creased from very few in cord blood to >50% in the sixth 
through eighth decades as (true) memory B cells accumu-
lated. We found, conversely, that the fraction of CD27+ B cells 
expressing  CD43  (CD20+CD27+CD43+)  declined  from 
Figure 4.  Adult peripheral blood CD20+CD27+CD43+ B cells exhibit tonic intracellular signaling. (A) Adult blood mononuclear cells were un-
exposed (0) or were exposed to pervanadate for 4, 8, or 12 min, and then fixed, permeabilized, and stained for surface antigens and intracellular phosphory-
lated PLC-2 with specific immunofluorescent antibodies. Because isotype control antibody staining by “fluorescence minus one” did not vary between 
the three cell populations under study, only a single control tracing is shown. Results for one of three comparable experiments are shown. (B) Mean val-
ues of MFI are shown (with error bars indicating the SEM) for intracellular phosphorylated PLC-2 staining at various time points from three separate 
adult blood samples. (C) Adult blood mononuclear cells were unexposed (0) or were exposed to pervanadate for 4, 8, or 12 min, and then fixed, permeabil-
ized, and stained for surface antigens and intracellular phosphorylated Syk with specific immunofluorescent antibodies. Results for one of three compa-
rable experiments are shown. (D) Mean values of MFI are shown (with error bars indicating the SEM) for intracellular phosphorylated Syk staining at 
various time points from three separate adult peripheral blood samples.JEM VOL. 208, January 17, 2011 
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Although the levels of CD69/CD70 expression on B1 
cells and activated memory and naive B cells are essentially 
nonoverlapping, indicating that they represent distinct B cell 
populations, we repeated functional assays with adult periph-
eral blood B1 cells in which the topmost 5% of B1 cells in 
terms of CD70 staining density were excluded (thereby in-
suring that no activated B cells with high CD70 expression 
would be present). We found no difference in IgM secretion, 
T cell stimulation, and tonic signaling in comparing CD20+ 
CD27+CD43+CD70  B  cells  with  CD20+CD27+CD43+  
B cells (unpublished data). Thus, the properties of human   
B1 cells cannot be accounted for by contaminating activated 
B2 cells.
Human B1 cells are not contained within the CD20  
B cell population
In identifying human B1 cells we focused on CD20+ B cells 
to avoid the few circulating terminally differentiating (CD20) 
plasma cells that have been reported in peripheral blood sam-
ples and that can secrete Ig (Radbruch et al., 2006). Umbilical 
cord blood lacks CD19+CD20 B cells 
(Fig. 9 A), and so it is clear that no ver-
sion of human B1 cells exists among 
putative CD20 B cells in cord blood 
because CD20 B cells do not exist in 
cord blood. However, in adult periph-
eral blood 1% of CD19+ B cells are 
CD20. This very small number, less 
than  1/10  the  number  of  CD20+ 
CD27+CD43+ B1 cells, suggests that 
if a version of human B1 cells exists 
among CD19+CD20 B cells in adult 
blood it would constitute a very small 
fraction of total B1 cells. To deter-
mine whether CD19+CD20 B cells 
from  adult  blood  meet  the  func-
tional criteria established for B1 cell 
status,  we  examined  spontaneous 
engagement with anti-IgM failed to up-regulate CD43 ex-
pression on previously CD43 B cells, we found that combi-
nations of SAC plus Il-2, PMA plus ionomycin, and anti-CD40 
plus anti-IgM did up-regulate expression. However, these ac-
tivated memory and naive B cells differed from unstimulated 
B1 cells in two important ways. First, activated, CD20+CD43+ 
fractions of previously CD43 memory (CD20+CD27+CD43) 
and CD43 naive (CD20+CD27CD43) B cells failed to 
spontaneously secrete IgM as detected by ELISPOT assay 
(unpublished data), and thus cannot account for this key B1 cell 
attribute. Second, activated, CD43+ fractions of previously 
CD43 memory and CD43 naive B cells expressed mark-
edly  elevated  levels  of  CD69  and  CD70  for  each  of  the 
CD43-inducing stimuli; such high levels of CD69 and CD70 
were not found on unstimulated B1 cells that are instead 
CD69lo/ and CD70 (Fig. 8). In fact, for all forms of CD43-
inducing stimulation, CD43+ activated memory (n = 3) and 
naive B cells (n = 3) were >99% positive for CD69 and >97% 
positive for CD70, whereas B1 cells (n = 3) were <3% posi-
tive for CD69 and <1% positive for CD70.
Figure 5.  CD20+CD27+CD43+ B1 cells 
display two typical B1 cell specificities. 
Adult peripheral blood mononuclear cells 
were immunofluorescently stained with  
specific antibodies and with either PC-BSA-
fluorescein (A and B) or biotinylated DWEYS 
tetramer plus PE-streptavidin (C and D), as 
described in the Materials and methods.  
Representative results are shown in A and C 
for three different B cell populations (CD20+ 
CD27+CD43+ B1 cells, CD20+CD27+CD43 
memory B cells, and CD20+CD27CD43  
naive B cells). (top) Gated CD20+CD43 cells; 
(bottom) gated CD20+CD27+CD43+ cells.  
Aggregate results are shown in  
B and D, with the proportion of B cells  
that bound antigen displayed on the  
Y axis as mean ± SEM, n = 4.74 Identification of human B1 cells | Griffin et al.
murine system, in which the use of CD5 to identify B1 cells 
has led to a rich accumulation of information concerning the 
unique developmental and behavioral characteristics of this   
B  cell  subset. We  have  now  examined  three  foundational   
features elucidated through studies of murine B1 cells and 
applied them to the human system by working in reverse to 
discover the surface antigens expressed on human B cells that 
exhibit these index functional characteristics. By evaluating 
spontaneous IgM secretion, efficient T cell stimulation, and 
tonic intracellular signaling, in conjunction with somatic   
hypermutation and repertoire skewing, we determined that 
human B1 cells are CD20+ B cells that coexpress CD27 and 
CD43 in both umbilical cord blood and in adult periph-
eral blood. The results are very clear cut in that not only do 
CD20+CD27+CD43+ cells express each of three key func-
tional characteristics, but other CD20+ B cell populations ex-
amined directly ex vivo do not express even one. Overall, this 
represents a major step forward in the translation of what is 
known about B1 cell physiology and pathology from animal 
models to the human condition, and will provide the means 
IgM secretion and tonic intracellular signaling (whereas in-
sufficient CD19+CD20 B cells were obtained to test T cell 
stimulation). We found that, as expected, CD19+CD20 B cells 
from  adult  blood  generated  IgM-containing  ELISPOTs   
(Fig. 9 B). In fact, the frequency and size of ELISPOTs pro-
duced by CD19+CD20 B cells was much greater than found 
in the ELISPOTs produced by CD20+CD27+CD43+ B cells 
from either cord or adult blood. Importantly, however, we 
found little or no increase in either phosphorylated PLC-2 
or phosphorylated Syk among CD19+CD20 B cells after 
phosphatase inhibition, in contrast to the marked increase 
observed in CD20+CD27+CD43+ B1 cells (Fig. 9, C and D). 
CD19+CD20 B cells fail to display tonic intracellular signal-
ing, and thus fail to express a key feature of B1 cells. There-
fore, as functionally defined, human B1 cells do not exist to a 
measurable extent within the CD19+CD20 B cell popula-
tion in adult blood.
DISCUSSION
The identity and even existence of human B1 cells has been 
in doubt for many years because of the absence of known cell 
surface markers for this population. This contrasts with the 
Figure 6.  CD20+CD5+ B cells are not the same as 
CD20+CD27+CD43+ B1 cells. Adult peripheral blood mononuclear cells 
were immunofluorescently stained with specific antibodies. The propor-
tion of CD20+CD27+CD43+ B1 cells that express CD5 (75 ± 2.5%; n = 46) 
is shown in A; the proportions of CD20+CD5+ B cells that phenotype as 
CD20+CD27+CD43+ (34 ± 3.0%; n = 46), CD20+CD27+CD43 (4.8 ± 0.41%), 
and CD20+CD27CD43 (61 ± 3.1%) are shown in B. Representative flow 
cytometry data are shown in Fig. S2.
Figure 7.  CD20+CD27+CD43+ B1 cells decline with age in normal 
individuals. (A) Cord blood (n = 6) and peripheral blood (n = 43) samples 
were stained with immunofluorescent antibodies and evaluated by flow 
cytometry. CD20+CD27+CD43+ B cells are expressed as a percentage of the 
total number of CD20+CD27+ cells at the ages indicated. The line through 
the datapoints represents a cubic regression curve fit (R-squared = 
0.070494). (B) Mean values for the proportion of CD43+ B cells among 
CD20+CD27+ B cells are shown for the indicated age intervals with error 
bars indicating the SEM.JEM VOL. 208, January 17, 2011 
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It  is  important  to  note  that  the  CD20+CD27+CD43+ 
cells we identified as human B1 cells are not in any way re-
lated to differentiated follicular B cells that might secrete IgM, 
such as plasma cells or plasmablasts, for the following reasons: 
human B1 cells expressed CD20 (which is lost during differ-
entiation at the plasmablast stage; Jego et al., 2001); human   
B1 cells did not express CD138 (which is acquired by differ-
entiated plasma cells; Klein and Dalla-Favera, 2007); and   
neither CD20 loss nor CD138 acquisition occurred during 
culture of human B1 cells with IL-6 for 5 d (unpublished 
data). Further, B1 cells are not contained within the very small 
excluded CD20 population because CD19+CD20 B cells 
showed no evidence of increased phosphorylated PLC-2 or 
phosphorylated Syk upon phosphatase inhibition; thus, they 
fail the test of tonic intracellular signaling and do not qualify 
as B1 cells according to the threefold functional criteria es-
tablished for this study. For this reason, in addition to the 
many  other  differences  between  CD20  plasma  cells  and 
to correctly determine the number and function of B1 cells 
in various disease states and in normal individuals at various 
stages of life.
Figure 8.  Expression of CD69 and CD70 differentiates B1 cells 
from activated memory and naive B cells. (A) CD20+CD27+CD43 
memory and CD20+CD27CD43 naive B cells were sort-purified from 
adult peripheral blood and were cultured with SAC (0.005%) plus IL-2  
(5 ng/ml) for 4 d, after which surface expression of CD43, CD69, and CD70 
was determined by immunofluorescent staining and flow cytometry. Un-
stimulated CD20+CD27+CD43+ B1 cells were immunofluorescently stained 
and analyzed for CD69 and CD70 at the same time. CD69 and CD70 ex-
pression is displayed for CD43+ B cells. Results are shown for one of three 
separate samples. Fluorescence minus one isotype control staining is 
shown in solid gray for each population. (B and C) Memory and naive  
B cells from adult blood were cultured for 4 d with SAC plus IL-2, PMA at 
100 ng/ml plus ionomycin at 400 ng/ml (P + I), or anti-CD40 at 10 µg/ml 
plus anti-IgM at 7 µg/ml (CD40 plus IgM), and immunofluorescently 
stained, after which surface expression of CD43, CD69, and CD70 was 
determined. Unstimulated CD20+CD27+CD43+ B1 cells were immuno-
fluorescently stained and analyzed at the same time. The proportion of 
CD43+ B cells that stained positively for CD69 (B) and for CD70 (C) is 
shown. Mean values for three separate adult blood samples for each  
population are shown along with error bars indicating SEM.
Figure 9.  Human B1 cells are not contained within the CD20  
B cell population. (A) Umbilical cord blood and adult peripheral blood 
mononuclear cells were stained with immunofluorescent antibodies and 
evaluated by flow cytometry. Expression of CD20 and CD19 is displayed. 
Representative results for one of three cord blood and one of three adult 
blood samples are shown. (B) CD19+CD20 B cells were sort-purified from 
adult blood and plated at 800 cells per well, incubated for 1 h at 37°C, 
and analyzed for IgM secretion by ELISPOT. The image shown is represen-
tative of three separate experiments on three different adult blood  
samples. (C) Adult blood CD19+CD20 B cells (thin black lines) and 
CD20+CD27+CD43+ B1 cells (thick black lines) were treated with the phos-
phatase inhibitor pervanadate. At the indicated times, B cells were immuno-
fluorescently stained and phosphorylation of PLC-2 (C) and Syk (D) was 
analyzed as described in the legend to Fig. 4. Results for one of three 
comparable experiments are shown.76 Identification of human B1 cells | Griffin et al.
Because only 0.5–3% of input CD20+CD27+CD43+ B1 
cells were positive on ELISPOT assay, it may be that another 
cell type, albeit not activated B cells, could be intermixed 
with this population, particularly in view of ELISPOT results 
on murine B1 cells, which detect almost an order of magni-
tude  greater  proportion  of  secreting  cells  (Tumang  et  al., 
2005; Holodick et al., 2010). It seems more likely, however, 
that the ELISPOT assay is not detecting all secreting B1 cells, 
inasmuch as detection depends on several variables, including 
the affinities of capture and detecting antibodies, the rate of   
Ig secretion, and the duration of ELISPOT incubation. We 
intentionally used a brief period of incubation so that results 
reflect in vivo events to the greatest extent possible. Impor-
tantly, the low proportion of ELISPOT positive human B1 cells 
cannot be attributed to secretion of another isotype, inasmuch 
as  >90%  of  CD20+CD27+CD43+  adult  peripheral  blood   
B1 cells (Fig. S2) and 100% of umbilical cord blood B1 cells 
(unpublished data) express IgD. It remains possible that the 
circulating pool of human B1 cells differs from B1 cells that 
are tissue-resident, and in that respect ELISPOT assays have 
not been performed on murine peripheral blood B1 cells. 
Still, results on tonic intracellular signaling reflect a single-cell 
population, and no other CD20+ B cell population showed 
even minimal secretion, so despite the small proportion of   
B1 cells that are positive on ELISPOT assay we suggest that 
this most likely represents a single type of B cell in which the 
test for Ig secretion is imperfectly sensitive.
As defined by CD20, CD27, and CD43, human B1 cells 
are for the most part CD5+, although some are CD5 negative. 
In preliminary experiments we found these two subpopula-
tions to be equivalent in IgM secretion, T cell stimulation,   
and tonic signaling (unpublished data) and the existence of 
CD20+CD27+CD43+CD5 B1 cells may explain previous 
reports that CD5 B cells are capable of producing autoreac-
tive and polyreactive antibodies. Importantly, CD5 positivity 
encompasses many B cells that are not B1 as defined herein, 
consistent with previous reports that follicular B cells at vari-
ous stages of development and activated B cells express CD5. 
Thus, isolating B1 cells as CD20+CD27+CD43+ provides a 
much more refined and discrete population as compared with 
the very heterogeneous nature of CD5+ B cells.
The phenotypic composition of B1 cells has already led to 
additional insights regarding human B cell populations. First, 
whereas peripheral (cord) blood at birth would seem to be 
necessarily devoid of memory B cells, as has been previously 
reported (Maurer et al., 1990; Agematsu et al., 1997), our re-
sults indicate that a population of CD27+ B1 cells is, in fact, 
present, as has been suggested (Shi et al., 2005), furthering the 
notion that CD27 is not an immutable indicator of memory 
B cell status, as also suggested by its presence on developing   
B cells (Nilsson et al., 2005). Second, whereas adult peripheral 
blood memory B cells have been reported to efficiently 
stimulate T cells (Good et al., 2009), our results indicate 
that this function is actually contributed by B1 cells con-
tained  within  the  CD27+  population  and  not  by  memory   
B cells, per se. In other words, CD20+CD27+ B cells represent a 
CD20+ B cells (Horst et al., 2002; Hogerkorp and Borrebaeck, 
2006; Radbruch et al., 2006), there is no evidence to suggest 
that any significant number of human B1 cells reside within 
the CD20 B cell population.
It is also important to note that the CD20+CD27+CD43+ 
cells we identified as human B1 cells are not contaminated with, 
and are not confused by, activated memory (CD27+CD43) 
or naive (CD27CD43) B cells. Although CD43 is associ-
ated with B cell differentiation, and not activation, in the   
murine system (Gulley et al., 1988), in the human system this 
surface antigen is up-regulated in previously CD43 B cells 
by some, but not all, activating stimuli, and so must be consid-
ered  an “activation  antigen.”  In  this  sense,  CD43  behaves 
much like CD5, which is also induced by activating stimuli 
(Freedman et al., 1989; Cong et al., 1991; but which, however, 
is still used effectively to delineate murine B1 cells). Further, 
activated B cells stimulate T cells and exhibit tonic signaling, 
and so B1 cells are not differentiated from activated B cells by 
these two functional criteria. In this two-way comparison, 
these assays represent qualifying criteria that candidate B cells 
must meet to be considered B1 cells, whereas in other two-
way comparisons these functional tests serve to distinguish B1 
cells (e.g., IgM-secreting CD20+ B1 cells versus IgM-secreting 
CD20 B cells). Despite these points of similarity (CD43 
expression, T cell stimulation, and tonic signaling), activated 
but not differentiated CD20+ memory and naive B cells fail 
to spontaneously secrete IgM. That rules out the possibility 
that CD20+CD27+CD43+ B cells are nothing more than 
activated  B  cells.  Moreover,  the  CD20+CD27+CD43+  
B cells that we have defined as B1 cells are not contaminated 
by activated B cells as far as can be determined because acti-
vated memory (CD20+CD27+CD43) or naive (CD20+ 
CD27CD43) B cells that up-regulate CD43 also express 
markedly elevated levels of CD69 and CD70, whereas B1 
cells  do  not  express  (CD70),  or  express  very  low  levels 
(CD69), of both of these antigens. In fact, the profile of CD69 
and CD70 expression by B1 cells is essentially devoid of cells 
with high expression, and thus it is highly unlikely that acti-
vated B cells are intermixed with the CD20+CD27+CD43+ 
B1 cell pool. This is consistent with current estimates that 
very, very few activated B cells actually circulate in the pe-
ripheral blood at any given time in normal individuals. 
Thus,  when  we  excluded  from  CD20+CD27+CD43+  
B cells those that expressed the topmost 5% staining den-
sity for CD70 during sort-purification (thereby insuring 
that no activated B cells with high CD70 expression would 
be present), we found no difference in IgM secretion, T cell 
stimulation, or tonic signaling in comparing CD20+CD27+ 
CD43+CD70 B cells with CD20+CD27+CD43+ B cells. 
Although there is no evidence that CD20+CD27+CD43+ 
human B1 cells contain activated B cells, and, in fact, there 
is clear evidence that this is not the case, an additional   
requirement that sort-purified B1 cells express no more 
than low levels of CD69 and/or CD70 provides redun-
dancy to ensure that activated memory and naive B cells 
are not present.JEM VOL. 208, January 17, 2011 
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likely that B1 cell protective IgM natural antibody also de-
clines with age, and this may explain, at least in part, the sus-
ceptibility of aged individuals to overwhelming infection by 
encapsulated organisms.
It has been conjectured for many years that the normal 
counterpart for malignant CD5-expressing chronic lympho-
cytic leukemia cells lies in human B1 cells; however, the   
identity of such cells has not been known up until now. 
With the characteristics of human B1 cells in hand, several 
similarities between normal human B1 cells and malignant 
chronic lymphocytic leukemia (CLL) cells, at least of the 
poor  prognosis  type,  are  evident.  For  example,  both  are 
CD20+CD27+CD43+CD70; most normal B1 cells express 
CD5, as do malignant CLL cells; and, both express relatively 
nonmutated Ig (Damle et al., 1999; Hamblin et al., 1999; Jung 
et al., 2003). In addition, we have found that normal human 
B1 cells ZAP-70 and ILT3 (unpublished data) like CLL cells 
(Best et al., 2006; Colovai et al., 2007). And, in respect to 
pathophysiology, the chronically activated phenotype of nor-
mal B1 cells may predispose to malignant transformation. 
Thus, in regard to CLL, in some respects we may be back to 
the future that was postulated 30 yr ago; to wit, that the nor-
mal counterpart cell for, and the target for malignant tran-
formation by, CLL is the human B1 cell, only now the true 
identity of the normal counterpart is known. This will, in 
turn, provide the means to carry out informative experi-
ments to elucidate the nature of CLL neoplasia by comparing 
malignant  CLL  cells  with  the  proper  corresponding  non- 
transformed B1 cells.
In summary, we have found that a small subset of human 
peripheral CD20+ B cells, specifically expressing CD27 and 
CD43 and present in both umbilical cord and adult peripheral 
blood, recapitulates key functional characteristics of murine 
B1 cells and for this reason is here denoted as the human   
B1 cell population. Identification of this population carries 
important implications for studying the normal behavior of   
B1 cells, for probing the production of natural Ig, for clarifying 
the functions previously ascribed to memory B cells, for de-
termining the origin of chronic lymphocytic leukemia, and 
for evaluating the pathophysiology of autoimmune dyscrasias.
MATERIALS AND METHODS
Donors and samples. Adult peripheral blood samples were obtained by ve-
nipuncture of adult volunteers after obtaining informed consent in accor-
dance with the Declaration of Helsinki. Additional samples in the form of 
leukopacks were obtained from the New York Blood Center on the day of 
donation. Anonymous umbilical cord blood samples were obtained from the 
Tissue Donation Program at The Feinstein Institute for Medical Research. 
This study was approved by, and all samples were obtained in accordance with, 
the Institutional Review Board of the North Shore-LIJ Health System.
Processing. All  blood  samples  were  treated  in  a  similar  manner  and   
processed promptly upon receipt. Mononuclear cells were obtained by   
density gradient separation using lymphocyte separation medium (Cellgro). 
Except  as  otherwise  noted,  mononuclear  cells  were  then  washed  and   
resuspended in RPMI 1640 (Cellgro) containing 10% fetal calf serum plus   
2  mM  l-glutamine,  10  mM  Hepes,  pH  7.25,  100  U/ml  penicillin,  and   
100 µg/ml streptomycin.
heterogeneous grouping that includes CD27+CD43+ B1 cells 
and CD27+CD43 “true” memory B cells. Thus, the features 
ascribed to memory B cells must now be reevaluated, and 
functional studies of CD27+ B cells should proceed only after 
depletion of CD27+CD43+ B1 cells to ensure a true memory 
B cell population.
The  confusion  between  CD27+CD43+  B1  cells  and 
CD27+ memory B cells may be particularly acute with re-
spect to so-called “IgM memory” B cells. Like B1 cells, IgM 
memory B cells express both IgM and CD27; however, as 
noted above in respect to all memory B cells, IgM memory   
B cells and B1 cells are two distinct populations separable by 
CD43 expression. IgM memory B cells lack the functional 
features of B1 cells; this is clear from the complete failure of 
CD27+CD43 B cells to secrete IgM, stimulate T cells, or   
exhibit tonic signaling, even though more than half of these   
B cells are IgM+. Thus, IgM memory B cells, constituting a 
substantial portion of CD27+ non-B1 cells, lack the charac-
teristics of B1 cells and are completely separable from them. 
Notably, it has been reported that IgM memory B cells are 
responsible for controlling infections produced by Streptococcus 
pneumoniae and other encapsulated organisms (Kruetzmann   
et al., 2003); however, the population of IgM memory B cells 
studied in previous work presumably included B1 cells be-
cause prior investigations used CD27 to identify memory   
B cells. Instead, it may be that (CD27+CD43+) B1 cells are 
responsible for producing anti-PC antibody in the human 
system as they are in the murine system, a notion sup-
ported by our finding that CD20+CD27+CD43+ B1 cells are   
repertoire-skewed to preferentially recognize PC in com-
parison  to  CD20+CD27+CD43  memory  B  cells  and 
CD20+CD27CD43 naive B cells (Fig. 5). This again em-
phasizes the importance of distinguishing B1 cells from 
memory B cells so that characteristics of the former not be 
attributed to the latter.
The number of human CD20+CD27+CD43+ B1 cells 
found in the peripheral circulation was small, and this raises 
the possibility that human B1 cells may be primarily located 
in a reservoir other than the peripheral circulation. This is, in 
fact, the situation with mouse B1 cells, which are located pri-
marily in coelomic cavities and the spleen. The report that 
anti-Streptococcus pneumoniae IgM memory B cells are gener-
ated in the spleen (Kruetzmann et al., 2003) is reminiscent of 
previous reports on mouse B1 cells indicating they also re-
quire the spleen for development (Wardemann et al., 2002), 
and again raises the possibility that at least some B cells previ-
ously described as IgM memory B cells may actually be   
human B1 cells.
Regardless of the relationship between human B1 cells 
and IgM memory B cells, the number of CD27+ B cells de-
clines with advancing age (Shi et al., 2005), and our results   
indicate  that  the  fraction  of  CD43+  B1  cells  within  the 
CD20+CD27+ population declines even more precipitously, 
particularly in the very old age group. Still, preliminary results 
suggest that the proportion of IgD+ B1 cells changes little 
with age and remains above 90%. Collectively, however, it is 78 Identification of human B1 cells | Griffin et al.
labeled  antibodies  (anti–CD20-APC-Cy7,  anti–CD27-V450,  anti–CD43-
FITC,  anti–CD70-PE,  anti–CD5-PE-Cy7,  anti–-IgD-PE,  anti–CD19-PE, 
anti–CD21-PE,  anti–CD44-PE,  anti–HLA-DR-PE,  anti-CD45RB,  anti–
phospho-PLC-gamma-2-A647, and anti–phospho-Syk-A647) were obtained 
from BD. Anti–CD69-PE was obtained from Beckman Coulter. Anti–CD43-
APC was obtained from eBioscience. PC-BSA-fluorescein was obtained from 
Biosearch Technologies. DWEYS tetramer protein was a generous gift from 
B. Diamond (The Feinstein Institute for Medical Research, Manhasset, NY). 
PE-Streptavidin was obtained from Biomeda.
Online supplemental material. Fig. S1 shows that umbilical cord blood 
B1 cells display preferential heavy chain variable gene usage. Fig. S2 shows 
that adult peripheral blood B1 cells express CD19, CD21, IgD, CD44, and 
CD45RB, but not all B1 cells express CD5. Table S1 shows actual sequences 
of Ig genes from umbilical cord B1 cells. Table S2 shows actual sequences of 
Ig genes from umbilical cord naive B cells. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20101499/DC1.
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